Viking Therapeutics Inc (VKTX)
52.62
+0.99
(+1.92%)
USD |
NASDAQ |
Nov 22, 16:00
52.65
+0.03
(+0.06%)
After-Hours: 20:00
Viking Therapeutics Free Cash Flow: -74.25M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -74.25M |
| June 30, 2024 | -71.94M |
| March 31, 2024 | -54.87M |
| December 31, 2023 | -73.38M |
| September 30, 2023 | -66.66M |
| June 30, 2023 | -60.50M |
| March 31, 2023 | -62.51M |
| December 31, 2022 | -48.40M |
| September 30, 2022 | -49.82M |
| June 30, 2022 | -47.25M |
| March 31, 2022 | -47.24M |
| December 31, 2021 | -47.59M |
| September 30, 2021 | -40.72M |
| June 30, 2021 | -35.12M |
| March 31, 2021 | -28.35M |
| December 31, 2020 | -21.78M |
| September 30, 2020 | -28.03M |
| June 30, 2020 | -26.11M |
| March 31, 2020 | -25.90M |
| December 31, 2019 | -24.75M |
| September 30, 2019 | -15.69M |
| Date | Value |
|---|---|
| June 30, 2019 | -17.79M |
| March 31, 2019 | -16.60M |
| December 31, 2018 | -18.76M |
| September 30, 2018 | -20.02M |
| June 30, 2018 | -17.85M |
| March 31, 2018 | -16.78M |
| December 31, 2017 | -14.76M |
| September 30, 2017 | -13.28M |
| June 30, 2017 | -12.60M |
| March 31, 2017 | -11.63M |
| December 31, 2016 | -11.07M |
| September 30, 2016 | -11.91M |
| June 30, 2016 | -12.65M |
| March 31, 2016 | -11.05M |
| December 31, 2015 | -8.732M |
| September 30, 2015 | -5.873M |
| June 30, 2015 | -3.082M |
| March 31, 2015 | -1.902M |
| December 31, 2014 | -1.591M |
| September 30, 2014 | -1.160M |
| June 30, 2014 | -0.5506M |
Free Cash Flow Range, Past 5 Years
-74.25M
Minimum
Sep 2024
-21.78M
Maximum
Dec 2020
-46.76M
Average
-47.42M
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Eli Lilly and Co | -2.275B |
| Pfizer Inc | 8.227B |
| Structure Therapeutics Inc | -104.33M |
| Altimmune Inc | -78.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.96M |
| Cash from Investing (Quarterly) | 25.90M |
| Cash from Financing (Quarterly) | 2.522M |
| Free Cash Flow Per Share (Quarterly) | -0.198 |
| Free Cash Flow Yield | -1.33% |